Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress

Journal of Physiology

Volumn 576, Issue 2, 2006, Pages 391-401

  Alfieri, Roberta R ^a   Bonelli, Mara A ^a   Cavazzoni, Andrea ^a   Brigotti, Maurizio ^b   Fumarola, Claudia ^a   Sestili, Piero ^c   Mozzoni, Paola ^a   De Palma, Giuseppe ^a   Mutti, Antonio ^a   Carnicelli, Domenica ^a   Vacondio, Federica ^a   Silva, Claudia ^a   Borghetti, Angelo F ^a   Wheeler, Kenneth P ^d   Petronini, Pier Giorgio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; COMPLEMENTARY DNA; CREATINE; CYCLOHEXIMIDE; DACTINOMYCIN; HYPERTONIC SOLUTION; INOSITOL; MESSENGER RNA; TAURINE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CELL TRANSPORT; CELL VIABILITY; CULTURE MEDIUM; DNA SYNTHESIS; ENDOTHELIUM CELL; INCUBATION TIME; KINETICS; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SYNTHESIS; STRESS; SWINE; AMINO ACID TRANSPORT; CONTROLLED STUDY; HYPEROSMOTIC STRESS; OSMOLARITY; REAL TIME POLYMERASE CHAIN REACTION; SUPPLEMENTATION; TRANSPORT KINETICS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CREATINE; CYCLOHEXIMIDE; DACTINOMYCIN; MEMBRANE TRANSPORT PROTEINS; MICE; MUSCLE HYPERTONIA; MYOBLASTS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RNA; RNA, MESSENGER; SWINE; WATER-ELECTROLYTE BALANCE;

EID: 33749328177     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.115006     Document Type: Article

References (50)

1. Alfieri RR, Bonelli MA, Petronini PG, Desenzani S, Cavazzoni A, Borghetti AF & Wheeler KP (2005). Hypertonic stress and amino acid deprivation both increase expression of mRNA for amino acid transport system A. J General Physiol 125, 37-39.
2. Alfieri RR, Cavazzoni A, Petronini PG, Bonelli MA, Caccamo A, Borghetti AF & Wheeler KP (2002). Compatible osmolytes modulate the responses of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 540, 499-508.
3. Alfieri RR, Petronini PG, Bonelli MA, Caccamo AE, Cavazzoni A, Borghetti AF & Wheeler KP (2001). Osmotic regulation of ATA2 mRNA expression and amino acid transport System A activity. Biochem Biophys Res Commun 283, 174-178.
4. Alfieri RR, Petronini PG, Bonelli M, Desenzani S, Cavazzoni A, Borghetti AF & Wheeler KP (2004). Roles of compatible osmolytes and heat shock protein 70 in the induction of tolerance to stresses in porcine endothelial cells. J Physiol 555, 757-767.
5. Allen EH & Schweet RS (1962). Synthesis of hemoglobin in a cell-free system. Properties of the complete system. J Biol Chem 237, 760-767.
6. Andres RH, Ducray AD, Huber AW, Perez-Bouza A, Krebs SH, Schlattner U, Seiler RW, Wallimann T & Widmer HR (2005). Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. J Neurochem 95, 33-45.
7. Beck FX, Burger-Kentischer A & Müller E (1998). Cellular response to osmotic stress in the renal medulla. Pflugers Arch 436, 814-827.
8. Beck FX & Neuhofer W (2005). Response of renal medullary cells to osmotic stress. Contrib Nephrol 148, 21-34.
9. Beis I & Newsholme EA (1975). The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J 152, 23-32.
10. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
11. Brigotti M, Petronini PG, Carnicelli D, Alfieri RR, Bonelli M, Borghetti AF & Wheeler KP (2003). Effect of osmolarity, ions and compatible osmolytes on cell-free protein synthesis. Biochem J 369, 369-374.
12. Burg MB (1995). Molecular basis of osmotic regulation. Am J Physiol 268, F983-F996.
13. Burg MB, Kwon ED & Kultz D (1997). Regulation of gene expression by hypertonicity. Annu Rev Physiol 59, 437-455.
14. Casey A, Constantin-Teodosiu D, Howell S, Hultman E & Greenhaff PL (1996). Creatine ingestion favourably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol 271, E31-E37.
15. Ceddia RB & Sweeney G (2004). Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J Physiol 555, 409-421.
16. Chen JG & Kempson SA (1995). Osmoregulation of neutral amino acid transport. Proc Soc Exp Biol Medical 210, 1-6.
17. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
18. Cuisinier C, Michotte De Welle J, Verbeck RK, Poortman JR, Ward R, Sturbois X & Francaux M (2002). Role of taurine in osmoregulation during endurance exercise. Eur J Appl Physiol 87, 489-495.
19. De Angelis E, Petronini PG, Borghetti P, Borghetti AF & Wheeler KP (1999). Induction of betaine-γ-aminobutyric acid transport activity in porcine chondrocytes exposed to hypertonicity. J Physiol 518, 187-194.
20. Denkert C, Warskulat U, Hensel F & Haussinger D (1998). Osmolyte strategy in human monocytes and macrophages: Involvement of p38 MAPK in hyperosmotic induction of betaine and myoinositol transporters. Arch Biochem Biophys 354, 172-180.
21. 31P magnetic resonance spectroscopy study. Neurol Res 22, 145-150.
22. +/Cl-co-transporter in the renal epithelial cell line NBL-1 under osmotic stress. Biochem J 319, 337-342.
23. Fumarola C, La Monica S, Alfieri RR, Borra E & Guidotti GG (2005). Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis. Cell Death Differ 12, 1344-1357.
24. +-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. J Biol Chem 268, 8418-8421.
25. 31P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest 29, 1060-1065.
26. Lawler JM, Barnes WS, Wu G, Song W & Demaree S (2002). Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290, 47-52.
27. Lenz H, Schmidt M, Welge V, Schlattner U, Wallimann T, Elsasser HP, Wittern KP, Wenck H, Stab F & Blatt T (2005). The creatine kinase system in human skin: Protective effects of creatine against oxidative and UV damage in vitro and in vivo. J Invest Dermatol 124, 443-445.
28. Manolopoulos VG, Droogmans G & Nilius B (1997). Hypotonicity and thrombin activate taurine efflux in BC3H1 and C2C12 myoblasts that is down regulated during differentiation. Biochem Biophys Res Commun 232, 74-79.
29. +/myo-inositol co-transporter. Nephrol Dial Transplant 14, 1217-1223.
30. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R & Beal MF (1999). Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157, 142-149.
31. Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R & Caligari M (2001). Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci 191, 139-144.
32. Murphy RM, Tunstall RJ, Mehan KA, Cameron-Smith D, McKenna MJ, Spriet LL, Hargreaves M & Snow RJ (2003a). Human skeletal muscle creatine transporter mRNA and protein expression in healthy, young males and females. Mol Cell Biochem 244, 151-157.
33. Murphy RM, Watt KKO, Cameron-Smith D, Gibbons J & Snow RJ (2003 b). Effects of creatine supplementation on housekeeping genes in human skeletal muscle using real-time RT-PCR. Physiol Genomics 12, 163-174.
34. Nomura A, Zhang M, Sakamoto T, Ishii Y, Morishima Y, Mochizuki M, Kimura T, Uchida Y & Sekizawa K (2003). Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro. Br J Pharmacol 139, 715-720.
35. - creatine transporter: functional, molecular characterization and localization. J Physiol 545, 133-144.
36. Petronini PG, Alfieri RR, Losio MN, Caccamo AE, Cavazzoni A, Bonelli MA, Borghetti AF & Wheeler KP (2000). Induction of BGT-1 and amino acid System A transport activities in endothelial cells exposed to hyperosmolarity. Am J Physiol Reg Integr Comp Physiol 279, R1580-R1589.
37. Pfaffl MW (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29, 2002-2007.
38. Powers AC (2005). Diabetes mellitus. In Harrison's Principles of Internal Medicine, 16th edn, ed. Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL & Jameson JL, pp. 2152-2180. McGraw-Hill, New York, USA.
39. Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, Stockler-Ipsiroglu G, Wallimann T & Priller J (2006). Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cereb Blood Flow Metab (in press).
40. Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostani D, Gioacchini AM & Stocchi V (2006). Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40, 837-849.
41. Sipila I, Rapola J, Simell O & Vannas A (1981). Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 304, 867-870.
42. Speer O, Neukomm LJ, Murphy RM, Zanolla E, Schlattner U, Henry H, Snow RJ & Wallimann T (2004). Creatine transporters: A reappraisal. Mol Cell Biochem 256 -257, 407-424.
43. Stout JR, Eckerson JM, May E, Coulter C & Bradley-Popovich GE (2001). Effects of resistance exercise and creatine supplementation on myasthenia gravis: A case study. Med Sci Sports Exerc 33, 869-872.
44. Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, Roy BD & Biggar D (2004). Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62, 1771-1777.
45. Tran TT, Dai W & Sarkar HK (2000). Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem 275, 35708-35714.
46. Volek JS & Rawson ES (2004). Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20, 609-614.
47. Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J & Malin JP (2000). Creatine therapy in myophosphorylase deficiency (McArdle disease): A placebo controlled crossover trial. Arch Neurol 57, 956-963.
48. Wyss M & Kaddurah-Daouk R (2000). Creatine and creatine metabolism. Physiol Rev 80, 1107-1213.
49. Zhao H, Hyde R & Hundal HS (2004). Signalling mechanisms underlying the rapid and additive stimulation of NKCC activity by insulin and hypertonicity in rat L6 skeletal muscle cells. J Physiol 560, 123-136.
50. Zorzano A, Fandos C & Palacin M (2000). Role of plasma membrane transporters in muscle metabolism. Biochem J 349, 667-688.